Huahaipharm especially in the field of cardiovascular Puri and Sartan drugs'
Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is a pharmaceutical company integrating pharmaceutical preparations and APIs. The company is a leading enterprise in the domestic specialty API industry, especially in the field of cardiovascular Puri and Sartan drugs, the company has the core technology and is currently the largest supplier of Puri and Sartan drugs in the world with the largest number of production varieties and leading technical level.
ResearchHealthcare, Technology, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchReal Estate, Industrials, Financials
Tech for Global, Globalization Footprints of the Established and the New
Dada group's revenue rose nearly 30% in the third quarter, and JD's "hour purchase" cont
Looking forward to the fourth quarter of 2021, dada Group expects its total revenue to be between 2 billion yuan and 2.1 billion yuan. On the premise that the last kilometer of dada express delivery service is consistent with the comparable basis, the total revenue in the fourth quarter of 2021 will achieve a year-on-year increase of 88% to 97%.
Nov 24, 2021 11:42 AM